Non-melanoma skin cancer – often called “white skin cancer” – is the umbrella term for skin cancers other than melanoma. Unlike melanoma, it does not arise from a dark mole but from a slowly growing, light-coloured, pearly, pink or skin-coloured bump, which is where the popular name comes from. Although it is the most common type of cancer worldwide, the treatment success rate exceeds 95% when it is diagnosed early. In this article you will find a detailed overview of the types, symptoms, risk factors, diagnosis and treatment of non-melanoma skin cancer, and how to protect yourself.
What Does “White Skin Cancer” Mean?
In the medical literature, “white skin cancer” is not an official diagnosis; it refers to the two main types grouped under non-melanoma skin cancer: basal cell carcinoma and squamous cell carcinoma. Both develop from cells in the epidermis, the outermost layer of the skin, and the vast majority appear on sun-exposed areas. Despite the name, these cancers are rarely truly white: they can be red, show small blood vessels, look like a sore or even be brownish.
Melanoma arises from the pigment-producing melanocytes, so it usually looks dark and behaves more aggressively. Non-melanoma skin cancers, on the other hand, develop from cells that contain no pigment, so they are usually light in colour, grow much more slowly and rarely spread. The most common problem with this disease is that it is mistaken for something “harmless” and neglected; if left untreated, it can invade surrounding tissue and advance into cartilage and bone, causing serious tissue loss.
Types of Non-Melanoma Skin Cancer
Basal Cell Carcinoma (BCC)
Basal cell carcinoma accounts for about 75–80% of all skin cancers and is the most common cancer in humans. It develops from the basal cells in the lowest layer of the epidermis. Its most distinctive features are that it grows extremely slowly and very rarely spreads to other parts of the body (metastasis). On the other hand, it can spread locally and cause permanent damage to delicate structures such as the nose, eyelids and ears.
It is most often seen on the areas most exposed to the sun, such as the nose, cheeks, forehead, eyelids, ears and scalp. There are different subtypes – nodular, superficial and morpheaform (sclerosing); because the morpheaform type has ill-defined borders, it requires more extensive surgery.
Squamous Cell Carcinoma (SCC)
Squamous cell carcinoma accounts for about 20% of non-melanoma skin cancers and is the second most common type. It arises from the flat (squamous) cells in the upper layers of the epidermis. It grows faster than basal cell carcinoma and, if untreated, carries a risk of spreading to the lymph nodes; this risk is higher on the lip and ear and in patients with a weakened immune system.
Squamous cell carcinoma often develops on top of precursor lesions called actinic keratoses. Actinic keratoses are small, rough, scaly patches that feel like sandpaper and form on skin that has been exposed to the sun for many years; because they are considered precancerous, they should always be assessed.
What Are the Symptoms of Non-Melanoma Skin Cancer?
Non-melanoma skin cancer is usually painless, which delays its detection. You should see a dermatologist if any of the following skin changes last longer than four to six weeks:
- A sore that does not heal: a wound that seems to heal but reopens, bleeds or crusts over.
- A pearly bump: a dome-shaped pink, whitish or skin-coloured nodule that shines in the light and may show fine blood vessels on its surface.
- A scaly red patch: a red, scaly area resembling eczema or psoriasis that may itch and does not clear up despite treatment.
- A hardened, scar-like area: a firm area with ill-defined borders where the skin looks waxy, tight and pale.
- A crusted, horn-like growth: a fast-growing, wart-like bump covered with a hard crust that is tender to the touch.
- A changing existing spot: an old spot that changes in size, colour, thickness or surface texture, bleeds or itches.
Changes on the side of the nose, the eyelid margin, the outer ear and the lower lip deserve particular attention, because in these areas the tumour can more easily invade deeper tissues.
Causes and Risk Factors of Non-Melanoma Skin Cancer
The main cause of non-melanoma skin cancer is damage to the DNA of skin cells caused by ultraviolet (UV) radiation and accumulated over many years. This is why the disease is most often seen on areas with high cumulative sun exposure, such as the face, neck, ears, backs of the hands and scalp.
Main risk factors
- Long-term, unprotected sun exposure; outdoor occupations.
- Use of sunbeds and artificial UV sources.
- Fair skin, blond or red hair, blue or green eyes; skin that burns easily and tans poorly.
- Sunburns in childhood and adolescence.
- Older age; the risk rises markedly after the age of 50.
- A previous skin cancer; the likelihood of a new lesion is high within the first five years.
- Use of immunosuppressive drugs after an organ transplant or because of a chronic disease.
- A history of radiotherapy, arsenic exposure, chronic wounds and burn scars.
- A family history of skin cancer and inherited syndromes such as xeroderma pigmentosum.
Although the risk is lower in people with darker skin, it is not zero; in this group lesions are often noticed later, so they may be at a more advanced stage at diagnosis.
How Is Non-Melanoma Skin Cancer Diagnosed?
Diagnosis begins with a full-body skin examination by a dermatologist. A suspicious lesion is examined with a magnifying, illuminated device called a dermatoscope; this method is highly accurate in distinguishing benign growths from cancerous lesions.
The definitive diagnosis is made by biopsy. All or part of the lesion is removed under local anaesthesia and sent for pathological examination; the result reveals the type of cancer as well as its subtype and degree of aggressiveness. For deep-seated, large or recurrent tumours, or when lymph node involvement is suspected, ultrasound, computed tomography or magnetic resonance imaging may be requested.
Treatment Options for Non-Melanoma Skin Cancer
The choice of treatment depends on the type, size, location and subtype of the tumour and on the patient’s age and general health. The main methods are:
Surgical excision
This is the most common method. The tumour is removed together with a margin of healthy tissue as a safety zone, and the removed tissue is examined by a pathologist. Small wounds are closed directly, while larger defects are repaired with a skin flap or graft repair.
Mohs micrographic surgery
This is a special technique in which the tumour is removed layer by layer and each layer is examined under the microscope during the operation. Because it requires specialised pathology and microscopy and a long operating time, it is not widely used in Turkey.
Curettage and electrodesiccation
In superficial, low-risk lesions, the tumour tissue is scraped away with a sharp spoon-shaped instrument and the base is cauterised. It is a quick and practical method, but it is not recommended for high-risk areas of the face or for aggressive subtypes.
Cryotherapy
This is freezing with liquid nitrogen. It is used less often for skin cancers, mainly for actinic keratoses and selected superficial lesions; temporary lightening of the skin may be seen after treatment.
Topical treatments and photodynamic therapy
Creams containing imiquimod or 5-fluorouracil can be used for superficial basal cell carcinoma and widespread actinic keratoses. In photodynamic therapy, a light-sensitive substance applied to the skin is activated with light of a specific wavelength to destroy abnormal cells. These methods give good cosmetic results but are only chosen for suitable patients. They are usually preferred to reduce the risk of recurrence.
Radiotherapy
It is used in elderly patients who are not suitable for surgery, in locations where an operation would cause loss of function, or as additional treatment after surgery.
Systemic treatments
In rare advanced and metastatic cases, targeted hedgehog pathway inhibitors and immunotherapy drugs that activate the immune system are used. These treatments are planned under the supervision of an oncologist.
How to Protect Yourself from Non-Melanoma Skin Cancer
Most non-melanoma skin cancers are preventable. The following protective measures are easy to build into everyday life:
- Use sunscreen: apply a broad-spectrum product with at least SPF 30, preferably SPF 50+, every day regardless of the season, and reapply every two to three hours.
- Avoid the midday sun: stay out of direct sunlight between 10 a.m. and 4 p.m. and seek shade.
- Use physical barriers: choose a wide-brimmed hat, UV-protective sunglasses and tightly woven, long-sleeved clothing.
- Avoid sunbeds: artificial UV sources markedly increase the risk of skin cancer.
- Examine yourself: once a month, in good light and with the help of a mirror, check your whole body, including the scalp and the area behind the ears.
- Have regular dermatological check-ups: if you are in a risk group or have had skin cancer before, have examinations at the intervals your doctor recommends.
- Protect children: sunburns in childhood permanently raise the risk in adulthood.
Course and Follow-Up of Non-Melanoma Skin Cancer
When basal cell and squamous cell carcinomas are caught at an early stage, the treatment success rate is very high; death from basal cell carcinoma is extremely rare. However, a significant proportion of people who have had skin cancer develop a new lesion within five years. Regular follow-up after treatment is therefore at least as important as the treatment itself.
Follow-up is usually more frequent in the first two years and then continues at yearly intervals. At each visit, both the operated area and the entire skin are examined.
Frequently Asked Questions
Can non-melanoma skin cancer be fatal?
The risk of death from basal cell carcinoma is extremely low. Squamous cell carcinoma can spread to the lymph nodes if neglected, follow a more serious course and carry a risk of death. In both types, early diagnosis is the most important factor determining the outcome.
Is non-melanoma skin cancer contagious?
No. Skin cancers are not passed from person to person; they arise from the uncontrolled multiplication of cells as a result of DNA damage.
How can I tell a mole from skin cancer?
An ordinary mole does not change noticeably over the years, has regular borders and does not bleed. Any lesion that grows, changes colour or surface, bleeds, itches or does not heal should always be assessed. The definitive distinction is made by dermatoscopic examination or, if necessary, a biopsy.
Will there be a scar after surgery?
Every surgical procedure leaves a scar, but how visible it is depends on the size and location of the tumour and the repair technique used. Plastic surgical reconstruction techniques markedly improve the cosmetic result.
Can it appear on areas not exposed to the sun?
It is less common but possible. Chronic wounds, old burn scars, areas treated with radiotherapy and a suppressed immune system are risk factors for such locations.
How often should I see a dermatologist?
For adults without risk factors, a skin examination once a year is sufficient. For people with fair skin, many moles, a family history of skin cancer or a previous skin cancer, this interval may be shortened to six months on the doctor’s advice.
How often should I see a plastic surgeon?
If a dermatologist has recommended a biopsy, you should see a plastic surgeon without delay to obtain a pathology sample. If you have had surgery for skin cancer by a plastic surgeon, check-ups are needed every three months in the first year and every six months thereafter, depending on the type and aggressiveness of the cancer.
Conclusion
Although non-melanoma skin cancer is the most common cancer in the world, it has one of the highest cure rates. The key to this success is early diagnosis. If you notice a sore that has not healed for a long time, a growing bump or a changing spot on your skin, seeing a dermatologist without delay both makes treatment easier and prevents permanent tissue loss. Making sun protection a daily habit is the most effective measure you have against this disease.
For a personal assessment of your situation, you can request an evaluation appointment; to learn about the surgeon’s training and experience, you can review the surgeon’s profile.
This content has been prepared for general information purposes and does not replace examination, diagnosis or treatment by a physician.
Assoc. Prof. Ahmet Hamdi Sakarya, MD, MSc
Specialist in Plastic, Reconstructive and Aesthetic Surgery
Assoc. Prof. Ahmet Hamdi Sakarya completed a two-year fellowship in reconstructive microsurgery and peripheral nerve surgery at Chang Gung Memorial Hospital in Taiwan, one of the world’s leading high-volume microsurgery centers. His clinical practice focuses on facial paralysis and facial reanimation, brachial plexus and other peripheral nerve injuries, functional muscle transfers, free tissue transfers and facial aesthetic surgery.




